Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

12.61 +0.34 (+2.77%)
Streaming Delayed Price Updated: 10:37 AM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 608,679
Open 12.36
Bid (Size) 12.59 (2)
Ask (Size) 12.60 (7)
Prev. Close 12.27
Today's Range 12.31 - 12.67
52wk Range 5.650 - 17.16
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Hims & Hers Stock Was Down This Week
An analyst feels that the bull run into the company has made it pricey on its valuations. 
Via The Motley Fool
The Disruptor’s Portfolio: 3 Stocks Shaping the New Economy
Leading the future economy, three disruptive stocks innovate with SoCs, strategic alliances, and digital health growth. 
Via InvestorPlace
Topics Economy
Exposures Economy

Performance

YTD
+30.81%
+30.81%
1 Month
-20.29%
-20.29%
3 Month
+38.72%
+38.72%
6 Month
+107.40%
+107.40%
1 Year
+12.69%
+12.69%

More News

Read More
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
From Hims & Hers Health, Inc.
Via Business Wire
Breaking Down Hims & Hers Health: 6 Analysts Share Their Views
Via Benzinga
Got $2,000? 2 Unbelievable Growth Stocks Up 58% and 30% to Buy in the New Bull Market
Via The Motley Fool
A Closer Look at Hims & Hers Health's Options Market Dynamics
Via Benzinga
Check Out What Whales Are Doing With HIMS
Via Benzinga
Looking Into Hims & Hers Health's Recent Short Interest
Via Benzinga
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
From Hims & Hers Health, Inc.
Via Business Wire
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
3 Disruptive Healthcare Stocks That Could Surge 1000% By 2028
Via InvestorPlace
3 Stocks With Unusual Call Option Activity
Via MarketBeat
Topics Economy
Exposures Interest Rates
LifeMD Shares Come Back to Life on GLP-1 Business Growth
Via MarketBeat
3 Stocks That Could Benefit from the Rise of Telemedicine
Via InvestorPlace
3 Market-Disrupting Stocks Primed for a 400% Leap in the Next 2 Years
Via InvestorPlace
Can WeightWatchers Regain its Mojo after Oprah Steps Down?
Via MarketBeat
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
From Hims & Hers Health, Inc.
Via Business Wire
3 Meme Stocks that r/WallStreetBets Loves (but Shouldn’t!)
Via InvestorPlace
2 Telehealth Stocks to Buy Hand Over Fist in March
Via The Motley Fool
Next-Gen Winners: 7 Tech Stocks Set to Dominate the Decade
Via InvestorPlace
Hims & Hers Stock Rises On Stimulating Earnings Growth
Via MarketBeat
The Top 7 Small-Cap Stocks to Buy in March 2024
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Hims & Hers Health Surges 30% After Earnings. Here Is Why the Stock Is Still a Magnificent Buy.
Via The Motley Fool
Maize and Blue Stock Pitch Competition 2024 Showcases Analytical Excellence With Surprising Results, Including A Bearish Call
Via Benzinga
3 Telehealth Stocks With Room to Run in 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.